Clinical Trials
Biogen completes enrollment in phase 3 STAR study of gene therapy timrepigene emparvovec to treat inherited retinal disorder
Biogen Inc, a global biotechnology company, announced the enrollment of the last patient in the global phase 3 STAR clinical study, which is evaluating the...
Clinical Trials
CRISPR Therapeutics, Vertex Report First Data from Trials of Gene-Editing Treatment CTX001
CRISPR Therapeutics and Vertex Pharmaceuticals reported preliminary, mostly-positive safety and efficacy data from the first two patients enrolled in two Phase I/II trials assessing their...
Clinical Trials
Signant Health and ActiGraphsimplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration
Signant Health, formerly CRF Health and Bracket, is proud to announce that it has integrated its industry leading eCOA platform TrialMax®, with ActiGraph’s Centre Pointsystem....
Clinical Trials
Thermo Fisher launches IonicX XRF Analyzer to identity ionic salts
Thermo Fisher Scientific has launched a new handheld X-ray fluorescence analyser called IonicX XRF Analyzer to help pharmaceutical and biopharmaceutical manufacturers to verify the identity...
Clinical Trials
WFS awarded GDP certifications for Johannesburg and Cape Town pharma facilities
Worldwide Flight Services (WFS) has become the first air cargo handling company in South Africa to be awarded Good Distribution Practice (GDP) certifications for its...
Clinical Trials
Cytel to hold Complex Innovative Trial Design Symposium
Cytel Inc., the leading global provider of innovative analytical software and consulting services to the life sciences industry, has announced that the Complex Innovative Trial...
Clinical Trials
Forbius completes enrollment into phase 1a solid tumour trial of AVID200
Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced that the Phase 1a solid tumor trial exploring the safety...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.